InMode Ltd. (INMD) Fair Value 2026

INMD · Medical Devices ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

8.5 /10

32 fundamental signals · 12 models active

Value Trap Risk

SAFE (21/100)

Quick Summary — As of 2026-08-27, InMode Ltd. (INMD) trades at $14.84, versus a $19.78 median fair value across its 12 active models — 33.3% above the current price. QOC: 8.5/10. Value Trap Risk: 21/100 (SAFE). 12/13 models active. Within that set, the Bayesian DCF component alone returns $20.01.

Key Facts

Ticker
INMD
Price
$14.84
Quality Score
8.5/10
Value Trap Risk
21/100
Models Active
12/13
Last Updated
Strength: First Chicago suggests +102.2% upside with 47% confidence
Risk: Limited model coverage (12/13) may reduce confidence

Is InMode Ltd. (INMD) Undervalued or Overvalued in 2026?

According to CirclFi’s 12-model valuation engine, InMode Ltd. (INMD) appears undervalued as of : the median of 12 independent fair value estimates is $19.78, 33.3% above the current price of $14.84. Estimates range from $8.32 to $31.34. INMD scores 8.5/10 on fundamental quality and 21/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -23.7% versus its own 13-model consensus, across 3,801 rated companies as of 2026-08-27. INMD’s +33.3% gap is wider than that market norm, and the Medical Devices sector median is -43.5%. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy InMode Ltd. Stock in 2026? →

What Fair Value Does Each Model Give INMD?

12 Intrinsic Value Models vs. Current Price ($14.84)

Core Models (Unlocked)
Model Fair Value Upside
Intrinsic · High Conviction
 $20.01 +34.9%
Intrinsic · High Conviction
 $19.55 +31.7%
Ensemble · Low Conviction
 $18.52 +24.8%
Scenario · Medium Conviction
 $30.01 +102.2%
Unlock the Full Matrix

Access 8 additional models including EROIC Spread, Markov DDM, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 12 Models →

Cancel anytime · No contracts · Instant access

What Is INMD's Fair Value Range?

Spread across 12 independent models · $8.32 to $31.34

CirclFi's 12 active models place InMode Ltd. (INMD) between $8.32 and $31.34 per share, a spread of 116% of the median. The median of that range — $19.78 — is the fair value CirclFi publishes for INMD, against a current price of $14.84.

Low · ML-RIVHigh · FTNN
$8.32median $19.78$31.34
Where the range comes from
Most bearish modelML Residual Income$8.32
Most bullish modelFTNN Topology$31.34
Model agreement8 bullish · 4 bearishwide

A band this wide is itself the finding. When independent methods land far apart, they are reading a business whose value depends heavily on which lens you apply — volatile earnings, heavy reinvestment, or an asset base that cash-flow and asset-based methods score differently. That disagreement is information: it says the choice of method matters more than usual for INMD. Treat the median as one reading among several and compare the individual models below before acting.

Every figure above is one model's standalone output on INMD, not a CirclFi price target. How each model works →

What Is InMode Ltd. (INMD) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, InMode Ltd.'s intrinsic value is estimated at $19.78, suggesting a +33.3% median upside from the current price of $14.84. While 8 models see room for appreciation, model agreement is not unanimous as 4 models flag potential overvaluation. Model dispersion is worth noting: FTNN targets $31.34 (+111.2%), versus ML-RIV at $8.32 (-43.9%). This +155.1% range highlights the importance of multi-model analysis rather than relying on any single methodology.

What Do the Models Say About INMD?

12 of 13 models are currently active for INMD. Of these, 8 models suggest upside while 4 models suggest overvaluation. Taken together, their median fair value for INMD is $19.78 — the figure CirclFi publishes as this stock's fair value. One component of that median, the Bayesian DCF, returns $20.01 on its own, implying +34.9% upside from the current price. See which stocks rank higher →

How Does INMD Rank in Medical Devices?

Among 157 Medical Devices stocks, INMD ranks #17 by Quality of Company score. CirclFi's QOC score of 8.5/10 evaluates 32 fundamental signals. A score of 8.5 places INMD in the top tier.

See all Most Undervalued Medical Devices Stocks →

InMode Ltd.'s positioning within the Medical Devices segment means that patent cliff exposure plays an outsized role in fundamental analysis. The sector's unique characteristics — including therapeutic area leadership — shape both the opportunity set and risk profile.

Is INMD a Value Trap?

CirclFi's Value Trap algorithm assigns INMD a score of 21/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

12 of 13 models are active for InMode Ltd.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, InMode Ltd. earns a quality score of 8.5/10. This robust rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency.

The gap between the most bullish and bearish model spans +155.1% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every INMD valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across INMD's 12 active models, average confidence is 39%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy InMode Ltd. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medical Devices Stocks Should You Also Analyze?

11 related Medical Devices stocks with 13-model coverage

SNNSmith & Nephew plcQOC 8.7CNMDCONMED CorporationQOC 8.5EWEdwards Lifesciences CorporationQOC 8.7XTNTXtant Medical Holdings, Inc.QOC 8.4ESMCEscalon Medical Corp.QOC 8.7ZBHZimmer Biomet Holdings, Inc.QOC 8.4NEOGNeogen CorporationQOC 6.9OWLTOwlet, Inc.QOC 5.8CSDXCS Diagnostics Corp.QOC 4.5IRMDIRADIMED CORPORATIONQOC 9.8PODDInsulet CorporationQOC 9.6

Read investment analysis: SNN · CNMD · EW · XTNT · ESMC · ZBH · NEOG · OWLT · CSDX · IRMD · PODD

Which Other Stocks Have a Similar Quality Score to INMD?

7 companies across all industries closest to INMD’s Quality of Company score of 8.5/10.

PLXSPlexus Corp.QOC 8.5DEDeere & CompanyQOC 8.5VLTOVeralto CorporationQOC 8.5UMBFUMB Financial CorporationQOC 8.5LOVEThe Lovesac CompanyQOC 8.5FHIFederated Hermes, Inc.QOC 8.5NVDANVIDIA CorporationQOC 10.0

Read investment analysis: PLXS · DE · VLTO · UMBF · LOVE · FHI · NVDA

Where Does INMD Sit in CirclFi's Medical Devices Rankings?

INMD is ranked against every other Medical Devices stock CirclFi covers in each of these screens.

See all Medical Devices stocks ranked →

What Else Do Investors Ask About InMode Ltd.’s Valuation?

What is InMode Ltd.'s intrinsic value in 2026?

CirclFi puts InMode Ltd. (INMD)'s intrinsic value at $19.78 — the median of 12 independent model estimates as of 2026-08-27, ranging from $8.32 to $31.34. One component of that median, the Bayesian DCF, runs 10,000 Monte Carlo simulations with jump-diffusion and returns $20.01 on its own. The Quality of Company score is 8.5/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is INMD overvalued or undervalued right now?

At $14.84, 8 of 12 active models suggest INMD may be undervalued, while 4 indicate potential overvaluation. The median of all 12 fair value estimates is $19.78, 33.3% above the current price of $14.84 — a consensus view that INMD is undervalued. The assessment depends on which methodology best fits InMode Ltd.'s business model in Medical Devices.

What does a Quality of Company score of 8.5 mean for INMD?

InMode Ltd.'s QOC of 8.5/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores above 7 indicate strong fundamentals and disciplined management.

How many valuation models does CirclFi run on INMD?

CirclFi analyzes INMD with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 12 of 13 are active for this stock. Read the full methodology →

Which valuation models are most bullish and most bearish on INMD?

Of the 12 models currently active on INMD, FTNN Topology is the most bullish at $31.34 per share, and ML Residual Income is the most bearish at $8.32. CirclFi's published fair value for INMD is the median of that range, $19.78, not either extreme. The gap between the two ends equals 116% of the median — a wide spread, meaning the methods genuinely disagree and the median should carry less weight. Browse stocks by value-trap risk →

Is INMD a value trap in 2026?

InMode Ltd.'s Value Trap score is 21/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap.

Cite this analysis — “According to CirclFi’s 12-model valuation engine, InMode Ltd. (INMD) has a median fair value of $19.78 — 33.3% above the current price of $14.84 — as of 2026-08-27.” Source: circlfi.com/stock/INMD/ · Methodology
Primary sources for this INMD valuation
  • Financial statements: InMode Ltd. 10-K and 10-Q filings on SEC EDGAR (CIK 0001742692) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for INMD as of ; valuations recomputed .

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 12 mathematical frameworks give you clarity on INMD.

Unlock All 12 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access

8 models hidden for INMD Unlock All 12 — $39/mo